Confidentiality Clauses for UK Health App Businesses

If you run a health app business in the UK, confidentiality terms can go wrong faster than most founders expect. A supplier sends over standard terms that let them reuse your product insights, a contractor agreement stays silent on patient data, or an NDA looks fine until you notice there is no clear return or deletion obligation. Those small drafting gaps can create big problems when your app handles health information, clinical workflows, product roadmaps, or sensitive commercial data.

For health app businesses, confidentiality is not just about keeping a concept secret. It often overlaps with privacy law, information security, intellectual property ownership, and the practical reality of sharing data with developers, clinicians, advisors, pilots, investors, and integration partners. If the clause is vague, too narrow, or inconsistent with how your business actually works, it may not protect what matters most.

This guide explains what confidentiality clauses for health app businesses usually cover, what UK companies should check before signing, where founders commonly get caught out, and how to make sure the wording reflects the risks of a health tech business rather than a generic software deal.

Overview

Confidentiality clauses for a health app should identify exactly what information is protected, who can use it, why they can use it, and what happens when the relationship ends. In the UK, that drafting often sits alongside data protection obligations, especially where the information could reveal health status, treatment, wellbeing patterns, or other special category personal data.

A clause that works for a standard software arrangement may be too weak for a health app pilot, data-sharing discussion, outsourced development project, or clinical collaboration.

• Define confidential information broadly enough to cover product plans, datasets, algorithms, clinical workflows, pricing, security processes, and patient-related material.
• Separate confidentiality promises from data protection obligations, especially where personal data and special category health data are involved.
• Limit use of the information to a clear purpose, rather than allowing general internal business use.
• Check who can receive the information, including employees, contractors, group companies, cloud providers, and advisors.
• Set out retention, deletion, and return obligations that reflect how digital information is actually stored.
• Make sure the clause addresses intellectual property and does not accidentally let another party reuse your app know-how.
• Review exclusions carefully, especially where information could become partly public or independently developed.
• Consider remedies, audit rights, security standards, and whether the clause survives termination for long enough.

What Confidentiality Clauses for Health App Means For UK Businesses

For a UK health app business, a confidentiality clause is a practical control on how sensitive information can be disclosed and used before you sign a contract and after the commercial relationship ends.

Founders often think of confidentiality as a short NDA signed at the start of a conversation. In practice, the more important wording is often buried in supplier agreements, pilot agreements, clinical partnership contracts, contractor terms, white label deals, and investment-related documents. If those clauses do not line up, your business may disclose highly sensitive material on weaker terms than intended.

Why health app businesses face higher confidentiality risk

Health apps routinely handle information that is commercially valuable and personally sensitive. Even if your app does not provide direct diagnosis or treatment, it may still process symptom logs, medication records, menstrual data, mental health entries, fitness data linked to health conditions, or communications with clinicians.

That matters because a confidentiality clause may need to protect several different categories of information at once:

• your confidential business information, such as pricing, fundraising plans, customer lists, product strategy, and partnership discussions
• technical information, such as source code, architecture, AI models, prompts, logic, security controls, and API documentation
• clinical or health-related information, whether de-identified, pseudonymised, or fully identifiable
• third party confidential material you receive from NHS bodies, clinics, insurers, research partners, or enterprise customers

This is where founders often get caught. A contract may protect only information marked confidential in writing, but much of what gets discussed in product calls, test environments, workshops, and pilot feedback is shared verbally or through live demos. If the clause is too formalistic, important information may fall outside protection.

Confidentiality is not the same as data protection

A confidentiality clause can restrict disclosure and misuse, but it does not replace UK GDPR compliance or a proper data processing arrangement. If another party will access personal data through your health app, you need to analyse the relationship properly.

For example, ask:

• are they acting as your processor, or are they a separate controller?
• will they access special category health data?
• do they need documented security obligations beyond the confidentiality wording?
• is there a lawful basis and, where required, an Article 9 condition for processing health data?

A short NDA will not answer those questions. You may need a separate data processing clause or agreement, plus a privacy notice and other privacy documentation that matches what actually happens with user data.

What a useful confidentiality clause usually does

A good confidentiality clause tells the other party exactly what they can and cannot do with your information. It should be specific enough to manage real risks, but not so narrow that obvious confidential material falls through the gaps.

Common elements include:

• a definition of confidential information
• the permitted purpose for disclosure and use
• limits on copying, storing, analysing, and sharing
• security standards and access controls
• rules for subcontractors and personnel
• return, deletion, and retention obligations
• exceptions, such as legally required disclosure
• survival after termination

For health app businesses, that wording should reflect the actual flow of information. If a software developer needs access to test datasets, a clinician advisor reviews product logic, or a pilot customer shares incident logs, the contract should say how that information is handled. Generic wording may not be enough.

Where these clauses usually appear

You may need confidentiality protections in more than one document. Common examples include:

• standalone NDAs before partnership or investment discussions
• supplier agreements with outsourced developers, designers, cybersecurity providers, and analytics vendors
• employment contracts and contractor agreements
• pilot agreements with clinics, healthcare providers, or enterprise customers
• research and product collaboration agreements
• integration agreements with platforms, device companies, or record system providers

Each document should be checked in context. The clause that is acceptable in an early investor NDA may be far too light for a vendor that can access live system information.

Legal Issues To Check Before You Sign

Before you accept the provider's standard terms, make sure the confidentiality drafting matches the information flows, technical setup, and regulatory exposure of your health app.

1. What counts as confidential information

The definition should be broad, practical, and not dependent on perfect admin. A clause that protects only information marked confidential can fail in real business use.

For most health app businesses, the definition should be wide enough to capture:

• business plans, pricing, forecasts, and fundraising information
• source code, object code, system architecture, and technical documentation
• algorithms, data models, prompt structures, and analytics outputs
• clinical logic, decision trees, treatment pathways, and product testing results
• security controls, incident records, and vulnerability information
• user data, health data, pseudonymised records, and support interactions
• third party confidential information that you are obliged to protect

If the other side insists on carve-outs, review them carefully. Publicly known information is commonly excluded, but that should not permit use of confidential material simply because one small part later enters the public domain.

2. Permitted use must be narrow

The clause should say the recipient may use the information only for a defined purpose. The main risk is wording that allows use for internal evaluation, service improvement, benchmarking, product development, or other broad commercial purposes.

That matters if you are sharing information with a software house, integration partner, or pilot customer. You may want them to assess your app or perform services, but not to use your workflows, commercial insights, or anonymised trend data to improve their own products.

Before you sign, look for language that allows:

• general business use
• product improvement using your information
• creation of derivative works
• training of AI models or internal tools
• aggregated or de-identified reuse without clear limits

Those rights can be much broader than they first appear.

3. Who can receive the information

Confidentiality promises are weaker if the recipient can share the information widely across affiliates, subcontractors, and advisors with little control.

The clause should cover onward disclosure properly. Usually, recipients may share information only with people who genuinely need it for the stated purpose and who are bound by equivalent obligations. If group companies or subcontractors are included, the main contract should make the recipient responsible for their compliance.

This is particularly relevant where a supplier uses offshore development teams, external security consultants, hosting providers, or support contractors. If your app deals with sensitive health data, you need to know who is actually getting access.

4. Data protection alignment

If the contract touches personal data, the confidentiality clause should not sit in isolation. The agreement may also need data protection wording that deals with processor obligations, security measures, sub-processors, breach reporting, international transfers, and assistance with data subject rights.

A common founder mistake is assuming a strong confidentiality clause solves privacy compliance. It does not. Confidentiality restricts misuse and disclosure. Data protection law governs whether the processing is lawful in the first place and what safeguards must be in place.

5. Security standards and handling rules

Where health or clinically sensitive information is involved, confidentiality wording is stronger when it includes practical handling expectations. You do not always need a long technical schedule, but the contract should reflect the level of risk.

Depending on the arrangement, you may want to address:

• access controls and least-privilege permissions
• encryption in transit and at rest
• segregation of development, test, and live environments
• restrictions on local downloads and portable media
• incident notification timeframes
• logging, monitoring, and evidence of deletion

If a clause says only that the recipient must keep information confidential, that may be too thin where practical security failures are the real risk.

6. Return, deletion, and retention

The contract should say what happens when the relationship ends or when information is no longer needed. Digital information often survives in backups, support tickets, shared drives, code repositories, and messaging tools.

Useful drafting usually covers:

• when information must be returned or deleted
• whether backup copies may be retained and on what conditions
• whether legal or regulatory retention is allowed
• what certification or evidence of deletion is required
• what happens to derived notes, extracts, and analysis

Without this, information can remain scattered across systems long after the commercial purpose has ended.

7. Intellectual property overlap

Confidentiality and intellectual property often interact. A supplier may promise not to disclose your information but still claim ownership of outputs created while using it. That can be a major issue for app features, datasets, user flows, documentation, or clinical content created during a project.

Before you rely on a verbal promise, check that the contract separately deals with ownership, licences, background IP, and any rights to use improvements or feedback. Confidentiality clauses do not automatically transfer IP rights.

8. Duration and remedies

A confidentiality obligation should last for a realistic period. For trade secrets, proprietary methods, and non-public technical know-how, a short survival period may be inadequate.

Also review what happens if the clause is breached. Some contracts mention injunctions or equitable relief. That can be useful, but remedies depend on the facts and the drafting should not create a false sense that enforcement is automatic. The key point is to make the obligation clear enough that a breach can be identified and addressed quickly.

Common Mistakes With Confidentiality Clauses for Health App

The most common mistake is treating confidentiality wording as boilerplate when your health app business relies on information that is both commercially valuable and legally sensitive.

Accepting a mutual NDA that is not really mutual

Many template NDAs look balanced at first glance. In reality, one party may have broad exceptions, broad internal use rights, or no meaningful deletion obligation. If you are the party disclosing the more sensitive material, those gaps matter.

This often happens in early partnership discussions, pilot negotiations, and outsourced build arrangements. Founders are keen to move quickly and accept standard terms without a proper contract review to check whether the practical burden falls mainly on them.

Using confidentiality wording that ignores health data realities

A generic software clause may not reflect the fact that your app handles special category data. If there is any possibility that shared information includes user records, support messages, testing data tied to individuals, or analytics that reveal health conditions, you need more than a simple promise not to disclose.

The clause should work alongside proper privacy and security terms. If it does not, your contract can look protective while leaving major compliance issues unresolved.

Allowing broad de-identified or aggregated data rights

Data reuse provisions are easy to miss. A supplier may say they can use aggregated, anonymised, or de-identified information for analytics, benchmarking, machine learning, or service improvement.

Sometimes that is acceptable. Often it is too broad. In health app settings, even de-identified information can raise commercial, ethical, and regulatory concerns. You should understand exactly what data is covered, whether re-identification risk has been considered, and whether the right is genuinely necessary.

Forgetting internal contracts

External NDAs get attention, but internal documents are just as important. Employees, contractors, consultants, and advisors may all access commercially sensitive and health-related material.

If your employment contracts and contractor agreements do not include suitable confidentiality and IP provisions, the business may have weak protection at the point where information leakage is most likely.

Relying on verbal assurances

Founders often hear statements such as, we will only use this to assess the integration, or we do not keep any copies after the pilot. If the contract does not say that clearly, the promise may be hard to enforce later.

Before you sign, get the limitations written into the agreement. The more sensitive the information, the less room there should be for assumptions.

Missing third party restrictions

Your business may hold confidential information that belongs partly or wholly to someone else, such as a clinic, research collaborator, enterprise customer, or NHS-related partner. If you disclose that information under a contract with weaker protections than your own upstream obligations require, you can create a chain of breach risk.

Always check whether you are passing on information subject to separate confidentiality, privacy, or data-sharing restrictions.

Using unrealistic deletion wording

Some contracts require immediate deletion of all copies on termination. That sounds neat but may be technically unrealistic if backups, archived emails, logs, and disaster recovery systems exist.

Better drafting is specific and workable. It should identify what must be actively deleted, what may remain in secure backups for limited periods, and what controls apply during retention.

FAQs

Do health app businesses need a standalone NDA every time?

No. Sometimes the main commercial contract contains adequate confidentiality terms. A standalone NDA is more common at the discussion stage, before a fuller agreement is signed.

Does a confidentiality clause cover personal health data automatically?

Not fully. It may restrict disclosure, but personal health data also requires proper data protection analysis and, where relevant, processor or controller wording.

Can a supplier use anonymised data from our health app?

Only if the contract allows it, and the wording should be reviewed carefully. In a health context, anonymisation and reuse rights need precise drafting because commercial and privacy risks can still remain.

How long should confidentiality obligations last?

That depends on the type of information. Short periods may be reasonable for some commercial discussions, but trade secrets, source code, security information, and non-public know-how often justify longer protection.

Should contractor agreements include confidentiality clauses too?

Yes. Contractors often access code, product strategy, user data, and clinical materials. Their agreements should cover confidentiality, permitted use, security expectations, and intellectual property ownership.

Key Takeaways

• Confidentiality clauses for health app businesses should be tailored to the information you actually share, not copied from a generic software template.
• In the UK, confidentiality and data protection are related but different, and health data often requires additional contractual safeguards.
• Before you sign, check the definition of confidential information, permitted use, onward disclosure rights, security standards, deletion terms, and survival period.
• Watch for broad rights to reuse de-identified data, improve products using your information, or share material across subcontractors and group companies.
• Make sure your NDAs, supplier contracts, pilot agreements, employment contracts, and contractor terms all work together consistently.
• Confidentiality clauses do not solve intellectual property ownership issues on their own, so the wider contract should deal with IP clearly.

If you want help with NDA terms, data protection clauses, supplier contracts, contractor agreements, or contract drafting, you can reach us on 08081347754 or team@sprintlaw.co.uk for a free, no-obligations chat.